Literature DB >> 5080031

Norethynodrel metabolites in human plasma and urine.

C E Cook, M E Twine, C R Tallent, M E Wall, R C Bressler.   

Abstract

Entities:  

Keywords:  Biology; Clinical Research; Contraception; Contraceptive Agents, Female--analysis; Contraceptive Agents, Progestin--analysis; Contraceptive Agents--analysis; Family Planning; Human Volunteers; Metabolic Effects; Norethynodrel--analysis; Oral Contraceptives; Physiology; Research Methodology; Steroid Metabolic Effects

Mesh：

Substances：

Year:  1972        PMID： 5080031

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN： 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  7 in total

1.  Metabolism of norethynodrel in thrombophlebitic-thromboembolic subjects.

Authors:  R W Handy; D Dominquez; M Poirier; M E Wall; C E Cook; C D Christian; R Bressler
Journal:  Experientia       Date:  1975-04-15

2.  Metabolism of the synthetic progestogen norethynodrel by human ketosteroid reductases of the aldo-keto reductase superfamily.

Authors:  Yi Jin; Ling Duan; Mo Chen; Trevor M Penning; Helenius J Kloosterboer
Journal:  J Steroid Biochem Mol Biol       Date:  2011-12-28       Impact factor: 4.292

Review 3.  Clinical pharmacokinetics of oral contraceptive steroids.

Authors:  M L Orme; D J Back; A M Breckenridge
Journal:  Clin Pharmacokinet       Date:  1983 Mar-Apr       Impact factor: 6.447

Review 4.  Pharmacologically active metabolites of drugs and other foreign compounds. Clinical, pharmacological, therapeutic and toxicological considerations.

Authors:  D E Drayer
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

5.  The metabolism of fluocortolone in the ram.

Authors:  R Lambe; S Hudson; D O'Kelly; A Darragh
Journal:  Ir J Med Sci       Date:  1978-11       Impact factor: 1.568

Review 6.  Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure.

Authors:  D E Drayer
Journal:  Clin Pharmacokinet       Date:  1976 Nov-Dec       Impact factor: 6.447

7.  Bioavailability of norethindrone in human subjects.

Authors:  R A Okerholm; F E Peterson; F J Keeley; T C Smith; A J Glazko
Journal:  Eur J Clin Pharmacol       Date:  1978-03-17       Impact factor: 2.953
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.